Closed · DARPA-BAA-09-43 · CFDA 12.910 · Discretionary

7-Day Biodefense

Federal grant opportunity posted by DARPA - Defense Sciences Office, cataloged on Grants.gov.

Varies
Award range
Closed
Status
June 21, 2010
Close date
-
Expected awards

The verdict

7-Day Biodefense is a closed discretionary listing from DARPA - Defense Sciences Office that offered Varies by applicant. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 175 other opportunities from DARPA - Defense Sciences Office.

Varies
award range
Closed
application status
12.910
CFDA program
175
other opportunities from DARPA - Defense Sciences Office

Archived opportunity record

7-Day Biodefense is closed (last close June 21, 2010). Check the agency catalog for replacement NOFOs. DARPA - Defense Sciences Office still indexes 175 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed June 21, 2010

Posted Jun 22 Closes Jun 21

Instrument

Procurement Contract

Description

DARPA is soliciting innovative medical therapeutic research proposals in two areas: Soldier Protection and Biodefense. Proposed research should investigate innovative approaches and revolutionary advances in science, devices, and/or systems. Specifically excluded are evolutionary or incremental improvements to existing practices.In recent years global surveillance networks have determined that the frequency and diversity with which new infectious microorganisms are emerging is increasing. While these increases are in part due to better reporting, there are multiple examples demonstrating this increase is promulgated by changes in natural systems, and potentially the activities of humans. Examples of factors implicated in the increase in new, emerging and re-emerging pathogens include: increased animal-human interface; increased population densities and co-location of vulnerable species with pathogen reservoirs; climate change, particularly affecting migration and spread of vectors; and narrowing of genetic diversity among food animal stocks. The expansion of biomedical technologies on the global stage is also suspected to increase the risk of orthogonal and highly diverse microorganisms. One growing concern is the potential risk posed by the proliferation of genetic engineering technologies that can be easily redirected from beneficent to offensive purposes or for covert biological industrial sabotage of food animals. Together, these natural occurring and synthetic threat agents challenge current detection methods and could possibly defeat traditional medical countermeasures. No group is at greater risk of exposure to new international pathogens, to bio-sabotage of food supply lines, or of attack from biological threat agents, then the U. S. Military. The traditional medical response for responding to large scale infectious disease outbreaks is to 1) quarantine exposed personnel (hours to weeks); 2) identify and characterize the agent (usually within 0-90 days); 3) develop a vaccine or therapeutic (1-14 years); and 4) to stockpile, distribute, and administer treatment. In cases where the pathogen is unknown or difficult to characterize, victims are likely to succumb before an effective therapy or vaccine can be developed, distributed and administered. DARPA/DSO is soliciting research proposals that seek to develop highly innovative approaches to counter any known, unknown, naturally occurring or engineered pathogen. Proposed research will investigate novel technologies to prevent infection, extend survival until a curative response is available, provide transient immunity, or speed the onset of adaptive immunity. Methods proposed should not require prior knowledge of the pathogen and should be broadly applicable to multiple unrelated infectious agents.7-Day Biodefense is a two phase program focused on four Technical Areas: 1) Prevent Infection; 2) Sustain Survival; 3) Provide Transient Immunity; and 4) Create Persistent Immunity. Each proposal must respond to only one of these technical areas and provide an aggressive research schedule with milestones that demonstrate a clear path to achieving the end of phase metric. There will be a Live Fire Test in Areas Three (Provide Transient Immunity) and Four (Create Persistent Immunity) to demonstrate capability against a DARPA-designated unknown biological agent in an animal model (details provided in these technical area descriptions).Novel approaches that obviate traditional and rate-limiting steps are of particular interest (e.g. pathogen isolation, culture, identification, antigen processing by the immune system, and onset of adaptive immunity). This BAA is seeking pre-clinical validation only. Human clinical trials are specifically excluded. Also excluded from consideration is research that results in incremental and evolutionary improvements to the existing state of practice (e.g. ventilator/mask technologies, use of traditional post-exposure antibiotics).

Catch-all / unrestricted eligibility mark · DARPA-BAA-09-43

Grants.gov marks 7-Day Biodefense with a catch-all / unrestricted eligibility code (Unrestricted / see official listing). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Procurement Contract. Funding-activity code maps to Science and Technology / R&D (ST). This eligibility-code string dominates the DARPA - Defense Sciences Office book (96 peers, 55% of 176).

Code 99
Unrestricted / see official listing

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

DARPA-BAA-09-43

What to do next

7-Day Biodefense is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 12.910 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants